iTeos Therapeutics, Inc. (ITOS)

iTeos Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-202.41	-134.41	-112.64	96.65	214.52	-38.03
Depreciation & Amortization	1.29	1.24	0.9	0.8	0.6	0.54
Stock-Based Compensation	27.13	29.94	27.02	21.56	13.79	4.29
Other Operating Activities	-12.11	-13.59	-10.23	-1.72	0.01	-1.3
Change in Accounts Payable	-5.13	-2.45	3.04	2.76	2.28	1.68
Change in Unearned Revenue	34.71	-0.57	-11.77	-267.23	277.65	1.79
Change in Income Taxes	4.4	4.44	-4.93	6.11	-7.54	-
Change in Other Net Operating Assets	44.06	17.22	4.87	29.87	11.83	5.87
Operating Cash Flow	-108.06	-98.18	-103.76	-111.19	513.14	-25.18
Capital Expenditures	-0.63	-1.63	-2.97	-0.94	-1.18	-0.36
Investment in Securities	57.45	-129.49	75.72	-445	-	-
Other Investing Activities	-0.05	-0.03	-0.1	-0.12	-0.06	-0.02
Investing Cash Flow	56.77	-131.15	72.66	-446.06	-1.24	-0.38
Issuance of Common Stock	4.85	122.72	1.11	0.93	2.94	214.32
Other Financing Activities	-0.48	-0.48	-	1.06	0.72	0.67
Financing Cash Flow	4.37	122.24	1.11	1.98	3.66	340.34
Foreign Exchange Rate Adjustments	3.66	-1.93	-3.6	-8.53	-3.18	1.68
Net Cash Flow	-43.26	-109.02	-33.59	-563.8	512.38	316.46
Free Cash Flow	-108.69	-99.81	-106.72	-112.13	511.96	-25.53
Free Cash Flow Margin	-	-285.18%	-847.34%	-41.90%	148.49%	-
Free Cash Flow Per Share	-2.51	-2.47	-2.98	-2.97	13.55	-1.69
Cash Income Tax Paid	2.41	4.03	6.82	22.82	32.02	0.11
Levered Free Cash Flow	-22.14	-64.35	-73.28	-150.04	431.68	-18.83
Unlevered Free Cash Flow	-22.14	-64.35	-73.28	-150.04	431.68	-18.83
Change in Working Capital	78.03	18.65	-8.8	-228.49	284.21	9.33

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q